Procedure-related complications tend to be unusual after RFA and tend to be dependent on the part of the body being treated.

No, ablation does not relate in any way to a coronary artery. Percutaneous Transluminal Coronary is the defining point to PTCA. Is the PTCA/Athr Intvl field tracking time between the last prior PTCA and CABG? So if a patient had a PTCA in 1984 and a CABG in 2000, would it be marked >6 hours? Or does this field pertain to PTCA/Ather Intvl during the admission of the CABG. Yes. Primary or direct stenting is done without angioplasty. All stent placement does not require angioplasty.

Minor complications include fluid around the heart or lung, breathing problems, nerve injury, pneumonia, and low blood pressure, bleeding or infection. Major complications include death, stroke, accidental damage to the normal pathway (the AV node) requiring a permanent pacemaker, perforation of the heart, heart attack, collapsed lung and blood-clot formation.

RFA has been used with success to treat primary liver cancer (otherwise known as hepatocellular carcinoma) and cancers that have spread to the liver from other places, such as colon cancer. Surgical resection of these tumors in carefully selected patients can lead to significant long-term survival but only a small percentage of these patients are candidates for surgery.

There are three basic types of systems used for RF ablation procedures. The specific RFA system and guidance method are chosen based on location and size of the tumor to be treated, proximity of large vessels, bleeding risk, the pathway that the needle-electrode has to take to enter the tumor, and the importance of minimizing collateral damage. The systems differ based on the length and configuration of the active tip of the needle-electrode.

Before the procedure, you will be asked to have nothing to eat or drink starting at midnight the evening before treatment. Your list of medications will be reviewed with our staff at the time of your consultation and you will be told which medications you may take in the morning of the procedure. If you are taking Coumadin, Plavix, or another blood thinner, you may need to stop taking that medication several days before the procedure.

Based on available data, outcomes appear to be excellent for patients with unresectable primary hepatocellular carcinoma. Reports show that well over 3,000 primary and metastatic liver tumors have been treated with RFA. These studies suggest that complete local response can be seen in 70-75% of patients with tumors ranging in diameter between 3 and 5 cm.

After the procedure, you may receive additional medication to prevent pain and nausea as the sedation wears off. Almost all of our patients are admitted overnight after the procedure to make sure that any pain is addressed with medication and to be certain that there are no post-procedure complications. You will need someone to take you home on the morning after the procedure. Once you arrive home, you can expect to have some mild post-procedure side effects.

After RFA, all patients require follow-up imaging on a regular basis to determine if the treated lesions have grown or if new lesions have developed. We typically perform a CT scan in 1 month, which then serves as our new “baseline” for future imaging. CT scans are then performed at 3 month intervals for 1 year. If the disease is stable at that point, this changes to performing CT scans at 6 month intervals.

Endovenous Radiofrequency Ablation is a minimally invasive procedure that has rendered vein stripping all but obsolete. The procedure consists of placing a catheter into the diseased vein through a needle puncture with virtually no scarring.   Radiofrequency energy (heat) is then applied that destroys the vein wall from the inside. There is minimal discomfort and patients typically resume their active lifestyles immediately.

The Radiofrequency ablation device used by the Liver Tumor Ablation Program has FDA 510K marketing authorization. The FDA typically does not approve devices but authorizes them for marketing. Surgical are not approved in the same manner as medications.

This is a procedure done at the surgery center to help control or stop abnormal bleeding or heavy periods. It is a painless and quick procedure done while you are asleep for 15 minutes. You can go home in 1 - 2 hours after the procedure and resume normal activity the next day. You cannot attempt pregnancy after this procedure is done. This is a simple option to alleviate abnormal bleeding and/or heavy periods without needing a hysterectomy!

The risks involved for ablation are bleeding at the puncture site and blood clot formation, which could result in a stroke, heart attack, or lung damage. Other possible complications are fluid build-up in the area around the heart, chest pain, valve damage within the heart, and a partial lung collapse. Occasionally complete interruption of the normal electrical system of the heart may occur and result in the need for a permanent pacemaker.

This effect disappears in a few minutes to a few hours. In the hands of an experienced laser technician using the right equipment, clients will not experience any damage to their skin. Many clients schedule treatments during their lunch break and return to their offices with no visible indications.

with any surgical procedure, there is some level of risk for the procedure. There are few risks involved with thoracoscopic surgery. Some are related to general anesthesia, chest surgery, and some are related specifically to TS SYM. These include bleeding, infection and pneumothorax or lung collapse. Those risks specific to sympathectomy include Compensatory Sweating and Horner’s Syndrome.

with all surgery, there are risks. Risks associated with cochlear implantation include infection, bleeding, imbalance, dizziness, taste disturbance on the side of the tongue undergoing surgery, and, rarely, facial nerve weakness. Fortunately, most risks/complications are unusual and when they do occur, these side effects are often short-lived.

There are fears that the electromagnetic radiation emitted from mobile phone handsets may harm health. In particular, there have been claims that it could affect the body's cells, brain or immune system and increase the risk of developing a range of diseases from cancer to Alzheimer's. Laboratory tests on mice have shown that radiation from mobile phones can have an adverse effect on their overall health. It is still not clear whether those findings can be applied directly to humans.

Physical risks, such as pain or bruising as a result of the blood draw and radiation exposure during the CAT scan. These risks tend to be very rare or minor. Emotional and psychological risks, such as some people become upset when they learn that they have a gene change that causes a disease.